ERBB2 and breast cancer: Human epidermal growth factor receptor 2 (HER2) could enhance kinase-mediated activation of downstream signal pathways, leading to cellular hyperproliferation and malignant transformation, and its significance in the pathogenesis and subsequent target therapy in breast cancer has been consolidated.